Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Phase 1 Recruiting
46 enrolled
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Phase 3 Recruiting
158 enrolled
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Phase 2 Recruiting
150 enrolled
(NeoScorch HN)
Phase 2 Recruiting
75 enrolled
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Phase 2 Recruiting
30 enrolled
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Phase 1 Recruiting
40 enrolled
OPTIFLAP
Phase 3 Recruiting
348 enrolled
Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
Phase NA Recruiting
20 enrolled
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Phase 2 Recruiting
189 enrolled
HOUSTON
Phase NA Recruiting
400 enrolled
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Phase 2 Recruiting
40 enrolled
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
Phase 2 Recruiting
174 enrolled
T-PROSE
Phase NA Recruiting
40 enrolled
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
Phase NA Recruiting
275 enrolled
Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Phase 2 Recruiting
28 enrolled
Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.
Phase NA Recruiting
60 enrolled
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Phase 2 Recruiting
98 enrolled
Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Phase 1 Recruiting
41 enrolled
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Phase 2/3 Recruiting
686 enrolled
AI Based Physiotherapy 3- and 9-Month Follow-Up in Oral Cancer Patients
Phase NA Recruiting
65 enrolled
Enhancing Oral Cancer Awareness
Phase NA Recruiting
60 enrolled
ENDURE
Phase NA Recruiting
532 enrolled
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
Phase NA Recruiting
80 enrolled
HexAgon-HN
Phase 2/3 Recruiting
410 enrolled
Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
Phase 4 Recruiting
425 enrolled
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
Phase 2 Recruiting
119 enrolled
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Phase NA Recruiting
50 enrolled
SURGIO
Phase NA Recruiting
200 enrolled
PRONTO-HN
Phase NA Recruiting
85 enrolled
AI-based Physiotherapy for Oral Cancer Patients
Phase NA Recruiting
100 enrolled
LAMBEAU STEPA
Phase NA Recruiting
40 enrolled
Role of Acetaldehyde in the Development of Oral Cancer
Phase NA Recruiting
170 enrolled
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Phase 2 Recruiting
50 enrolled
ViPMR
Phase 2/3 Recruiting
420 enrolled
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population
Phase 2 Recruiting
25 enrolled
Radial Forearm Donor Site Closure
Phase NA Recruiting
120 enrolled
PGSRT
Phase NA Recruiting
40 enrolled
Brodalumab in the Treatment of Immune-Related Adverse Events
Phase 1 Recruiting
11 enrolled
Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers
Phase NA Recruiting
1,206 enrolled
Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Phase NA Recruiting
118 enrolled
RADIAN
Phase 1/2 Recruiting
34 enrolled
SurVIC
Phase 3 Recruiting
346 enrolled
GuidedbyLight
Phase 2 Recruiting
28 enrolled
KEVLARx
Phase 2 Recruiting
216 enrolled
Neck Observation or Elective Neck Dissection in CT1N0M0 OSCC
Phase NA Recruiting
300 enrolled
NANOSCAN
Phase NA Recruiting
29 enrolled
TACO
Phase NA Recruiting
30 enrolled
Ronco-Onco
Phase NA Recruiting
35 enrolled
Early Feeding After Oral Cavity Reconstruction
Phase NA Recruiting
89 enrolled
SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx
Phase 2 Recruiting
25 enrolled